Goldman Sachs warns about the risks of high concentration in European equities, as top companies see falling market caps and ...
Eurofins Scientific's post-COVID EBITDA slump is expected to rebound with aggressive growth targets. Click here to find out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback